Dezaguanine
Alternative Names: 3 DG; CI 908; Deazaguanine; ICN 4221; NSC 261726; Oncozole; PD 9069573Latest Information Update: 28 Nov 2000
At a glance
- Originator Viratek
- Class Antineoplastics; Small molecules
- Mechanism of Action DNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 28 Nov 2000 No-Development-Reported for Cancer in USA (Unknown route)